2019
DOI: 10.2337/db20193
|View full text |Cite
|
Sign up to set email alerts
|

PREVENTION AND MANAGEMENT OF Diabetes-Related Eye Disease

Abstract: Novartis, Regeneron, Regenxbio, and Roche; and is a speaker for Regeneron. B.A.C. has been a speaker for Novo Nordisk and served on an advisory board for Regeneron. No other potential conflicts of interest relevant to this compendium were reported. About the Cover Proliferative diabetic retinopathy showing neovascularization and scar tissue, a condition that needs immediate surgery. Credit: Visuals Unlimited, Inc. / Chris Barry / Getty Images22 | References horizontal diplopia and a lateral out-turning of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 67 publications
0
1
0
Order By: Relevance
“…The objective was to use non-invasive methods, which would not be time-and cost-consuming, yet would be helpful in routine tests. In the case of diabetes mellitus, a systemic disease (DM), routine ophthalmological examinations have become a standard practice [11]. The goal is to detect ocular complications of the disease, even before the patients notice any symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…The objective was to use non-invasive methods, which would not be time-and cost-consuming, yet would be helpful in routine tests. In the case of diabetes mellitus, a systemic disease (DM), routine ophthalmological examinations have become a standard practice [11]. The goal is to detect ocular complications of the disease, even before the patients notice any symptoms.…”
Section: Introductionmentioning
confidence: 99%